Recent advances in the management of secondary hypertension—obstructive sleep apnea

Tomotake Tokunou, Shin ichi Ando

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Since obstructive sleep apnea (OSA) is known as a common cause of secondary hypertension, it is necessary to consider OSA a differential diagnosis in treating patients with hypertension. Apnea during sleep causes temporary and repeated hypoxia and subsequent sympathetic nerve activation. Furthermore, dysfunction of endothelial cells due to hypoxia is considered another mechanism leading to enhanced stiffness of the elastic artery and eventually, elevation of blood pressure (BP). As a result, OSA induces a nighttime or morning surge in BP, and long-standing severe OSA also causes daytime hypertension. Therefore, treatment of OSA may be important for BP control, especially in severe OSA cases. For the treatment of OSA, continuous positive airway pressure (CPAP) is a major treatment option, though alternative devices may be useful in CPAP-intolerant cases.

Original languageEnglish
Pages (from-to)1338-1343
Number of pages6
JournalHypertension Research
Volume43
Issue number12
DOIs
Publication statusPublished - Dec 2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Recent advances in the management of secondary hypertension—obstructive sleep apnea'. Together they form a unique fingerprint.

Cite this